Published on

October 22, 2020

Last updated on

March 29, 2022

China Implements Easier Transition for Localization of Overseas Manufacturers

China Implements Easier Transition for Localization of Overseas Manufacturers

According to the NMPA’s (National Medical Products Administration’s) announcement released on September 18, overseas manufacturers of class II and III medical devices and IVDs can establish a foreign-owned enterprise and set up a local production site in China by fulfilling the requirements highlighted in the following:

  • The class II or III overseas medical devices and IVDs are already in the market and registered in China
  • The applicant’s information of the new registration (foreign-owned enterprise) must be the same with the original registration (importing device), except for the name, address, and factory address of the applicant
  • Applicants should refer to the dossier requirements of medical devices and IVDs in China for the registration process
  • Successfully registered foreign-owned enterprises must indicate the registration number of the importing device (from the original registration) in the new registration certificate

By Jacky Li. Contact Cisema if you would like to learn more.

Connect with Cisema

With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.

Talk to an Expert
Explore Whitepapers

Stay Informed with Monthly News and Analysis

Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.

Sign Up for Newsletter

Contact Our Consultants & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal